Cameco Corp (CCJ) concluded trading on Wednesday at a closing price of $44.72, with 5.07 million shares of worth about $226.89 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 4.95% during that period and on Wednesday the price saw a gain of about 2.59%. Currently the company’s common shares owned by public are about 435.31M shares, out of which, 433.76M shares are available for trading.
Stock saw a price change of -3.93% in past 5 days and over the past one month there was a price change of -5.87%. Year-to-date (YTD), CCJ shares are showing a performance of -12.98% which increased to 11.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $35.43 but also hit the highest price of $62.55 during that period. The average intraday trading volume for Cameco Corp shares is 4.09 million. The stock is currently trading -6.71% below its 20-day simple moving average (SMA20), while that difference is down -11.53% for SMA50 and it goes to -10.07% lower than SMA200.
Cameco Corp (NYSE: CCJ) currently have 435.31M outstanding shares and institutions hold larger chunk of about 76.16% of that.
The stock has a current market capitalization of $19.47B and its 3Y-monthly beta is at 1.03. PE ratio of stock for trailing 12 months is 157.80, while it has posted earnings per share of $0.28 in the same period. Its PEG reads 2.93 and has Quick Ratio of 0.92 while making debt-to-equity ratio of 0.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCJ, volatility over the week remained 4.75% while standing at 4.11% over the month.
Stock’s fiscal year EPS is expected to rise by 122.82% while it is estimated to increase by 32.56% in next year. EPS is likely to grow at an annualized rate of 53.82% for next 5-years, compared to annual growth of 15.41% made by the stock over the past 5-years.
Coverage by Goldman stated Cameco Corp (CCJ) stock as a Buy in their note to investors on April 01, 2024, suggesting a price target of $55 for the stock. Stock get an Outperform rating from BMO Capital Markets on November 08, 2023.
